Which specialist diet is best for Parkinson’s disease?
Recipes & Nutrition
Author: Kathrynne HoldenPublished: 29 September 2016
Prep: -Cook: -Serves: -
Ex-National Parkinson Foundation dietician, Kathrynne Holden, discusses the specialist diets that studies have found to be beneficial in improving Parkinson’s symptoms
What diet is best for Parkinson’s disease? This is a question I’ve been asked hundreds of times down through the years, and I understand why. Parkinson’s disease is a complex condition, difficult to understand, and it often creates many nutritional problems. There can be protein interactions with levodopa, unplanned weight loss or gain, chewing and/or swallowing problems, among others.
And, we all would like to know if any dietary means could slow progression of Parkinson’s disease. Yet, there is no single ideal diet for everyone with Parkinson’s disease.
There are about 7.5 billion people in the world. Like our DNA strands, every one of these individuals is different, with different nutrient needs, metabolic pathways, food allergies and aversions, and available food supply among many other differences.
So I have been reluctant to endorse a great many of the numerous diet plans that have appeared over the years. Why? Because a) they often have a “one size fits all” approach, whereas there is no diet that is suitable for everyone with Parkinson’s; and b) very few have reliable research on safety or effectiveness to back them up. Some are extremely restrictive, potentially dangerous, and require trials, to determine whether they are safe and effective.
The diet plans listed below have all shown promise via academic research.
There are several versions of the paleo diet, including the Wahls Protocol, developed for Multiple Sclerosis (MS). The emphasis is on animal protein, fats, and non-starchy vegetables, while avoiding grains, milk and dairy products, beans/legumes, plant oils, and processed foods.
Reportedly, Parkinson’s disease symptoms improve, pain diminishes, and progression of the condition appears to be slowed, although as of this writing, research to confirm effects upon Parkinson’s disease is lacking.
A review of research for cancer and metabolic syndrome, however, found three published studies that showed the Mediterranean, Paleolithic and Dietary Approaches to Stop Hypertension (DASH) diets showed promise for reducing risk for colorectal cancer.[i] A larger study found an association between paleolithic and Mediterranean diet patterns and lower levels of inflammation and oxidative stress, decreasing risk for cancer and other chronic diseases.[ii] Reviewers studying trials of paleolithic diets versus other diets to treat metabolic syndrome, found that the paleolithic diet resulted in greater short-term improvements in metabolic syndrome components than did control diets.[iii]
Although not yet conclusive, these are all encouraging. However, no research has yet addressed the paleolithic diet for use in Parkinson’s disease.
There are some individuals with Parkinson’s disease whose gastrointestinal tract is affected by gluten, a protein found in wheat, barley, and rye grains. This can be due to celiac disease, non-celiac gluten sensitivity, or an allergy to gluten. Some have intestinal permeability, known as ‘leaky gut.’ Leaky gut may be caused by small intestine bacterial overgrowth, by celiac disease, or by an autoimmune reaction. For these people, avoidance of gluten-containing grains may help lessen Parkinson’s disease symptoms. There is a case study of a gentleman diagnosed with Parkinson’s who was found to have ‘silent celiac disease.’ When gluten was removed from his diet, he experienced almost complete relief from Parkinson’s disease symptoms.[iv]
Interestingly, a small study found that Parkinson’s disease symptoms improved by eliminating red meat while supplementing with the B vitamin riboflavin.[v] However, the study, of only nineteen individuals, was too small to provide conclusive evidence. It is likely that some people will benefit from a vegetarian diet, perhaps due to the prebiotic content of foods consumed, or to the fiber, antioxidants or other nutrients in the regimen.
The ketogenic diet has been in use for nearly a century to treat epilepsy. It is high in fat, and low in the protein and carbohydrates, which are normally used as fuel sources. This forces the body to use stored fat to produce ketone bodies to use for fuel.
In Parkinson’s disease, a weakened mitochondrial function is thought to be involved in the death of neurons that supply dopamine. Researchers theorise that ketone bodies may protect the mitochondria and support their function.
In a small study, five patients with Parkinson’s disease used the ketogenic diet for four weeks. Their UPDRS scores improved, dropping by 43%, which is very encouraging, although study authors could not rule out a placebo effect.[vi] However, cell and animal studies have showed promise, and researchers continue to study the diet for use in Parkinson’s and other neurodegenerative disorders.
The diet is considered difficult to prepare, and for many people also difficult to maintain. It should not be attempted except under the supervision of a physician and qualified dietitian.
The Mediterranean way of eating is based on a variety of fresh, unprocessed vegetables and fruits, fish, small amounts of meat and poultry, beans of all kinds, and whole grains like spelt, barley, farro, and traditional strains of wheat. Fish, especially fatty fish, like herring, sardines, and salmon, have been shown to support the brain and nervous system. Vegetables, fruits, and whole grains contain valuable antioxidants, vitamins, minerals, fibers, and polyphenols (antioxidant phytochemicals found in plant foods). These destroy the free radicals caused, in some cases, by the stresses of Parkinson’s disease.
The diet has not been studied specifically for Parkinson’s disease. However, its high polyphenol content appears to protect against amyloid deposits – abnormal clumps of proteins that cause diseases such as Parkinson’s disease and Alzheimer’s disease. In experimental studies, resveratrol, a polyphenol found in grapes, red wine, nuts and dried fruits, has been found to be neuroprotective, although human studies have yet to be conducted.[vii]
There are many other diets and eating plans – raw foods, fruitarian, vegan, for example – and the future will surely see still more.
Look out for part two of Kathrynne’s Parkinson’s diet analysis in the coming weeks
[i] Godos J1, Bella F1, Torrisi A1, Sciacca S1, Galvano F2, Grosso G1. Dietary patterns and risk of colorectal adenoma: a systematic review and meta-analysis of observational studies. J HumNutr Diet. 2016 Jul 14.
[ii] Whalen KA1, McCullough ML2, Flanders WD3, Hartman TJ4, Judd S5, Bostick RM6.Paleolithic and Mediterranean Diet Pattern Scores Are Inversely Associated with Biomarkers ofInflammation and Oxidative Balance in Adults. J Nutr. 2016 Jun;146(6):1217-26.
[iii] Manheimer EW1, van Zuuren EJ2, Fedorowicz Z3, Pijl H4. Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr. 2015 Oct;102(4):922-32.
[iv] Di Lazzaro V1, Capone F, Cammarota G, Di Giuda D, Ranieri F. Dramatic improvement of Parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease. JNeurol. 2014 Feb;261(2):443-5.
[v] Coimbra CG, Junqueira VB. High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson’s disease patients. Braz J Med BiolRes. 2003 Oct;36(10):1409-17.
[vi] Vanitallie TB1, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson’s disease with diet-induced hyperketonemia: a feasibility study. Neurology. 2005 Feb22;64(4):728-30.
[vii] López-Miranda V1, Soto-Motenegro ML, Vera G, Herradón E, Desco M, Abalo R. Resveratrol; a neuroprotective polyphenol in the Mediterranean diet. Rev Neurol. 2012 Mar 16;54(6):349-56.
Innovative remote management gait guidance system is to launch soon
1 day ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”